Home > Qtrly Results > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Quarterly Results Analysis [Sep2024]

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Quarterly Results

Consolidated Sep2024
Audited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Revenues ₹32 Cr ₹244 Cr ₹43 Cr ₹32 Cr ₹23 Cr ₹235 Cr ₹45 Cr ₹25 Cr
Expenses ₹27 Cr ₹207 Cr ₹39 Cr ₹26 Cr ₹18 Cr ₹198 Cr ₹41 Cr ₹20 Cr
Operating Income ₹5 Cr ₹37 Cr ₹4 Cr ₹6 Cr ₹5 Cr ₹37 Cr ₹4 Cr ₹6 Cr
Other Income ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹3 Cr ₹2 Cr ₹1 Cr ₹3 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹3 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹1 Cr ₹34 Cr ₹2 Cr ₹5 Cr ₹2 Cr ₹33 Cr ₹2 Cr ₹2 Cr
Profit After Tax ₹1 Cr ₹33 Cr ₹2 Cr ₹4 Cr ₹2 Cr ₹33 Cr ₹1 Cr ₹1 Cr
EPS ₹0.59 ₹17.55 ₹1.38 ₹2.01 ₹0.80 ₹17.47 ₹0.76 ₹0.71
Industry Peers & Returns1W1M1Y
NATH BIOGENES (INDIA) -1.4% -12.9% -14%
BOMBAY BURMAH TRADING CORPORATION -3.9% -6.7% 67.7%
KAVERI SEED COMPANY -4% -4.8% 38.4%
VENKYS (INDIA) -1.3% -1.2% -15.9%
BOMBAY SUPER HYBRID SEEDS -7.3% -13.4% -38.7%
TIERRA AGROTECH 1.3% -1.2% -39.4%
INDO US BIOTECH -3.1% -0.8% 16.5%
MANGALAM SEEDS -12.1% -13.4% -8.9%
SHREE OSWAL SEEDS AND CHEMICALS -10.3% -15.7% -61.3%

NATH BIOGENES (INDIA) Quarterly Revenues

Revenues
Q-o-Q

-86.80 %

Y-o-Y

42.65 %

Quarters Revenues % Change
Sep2024 ₹32 Cr
-86.80
Jun2024 ₹244 Cr
466.65
Mar2024 ₹43 Cr
35.60
Dec2023 ₹32 Cr
40.63
Sep2023 ₹23 Cr
-90.41
Jun2023 ₹235 Cr
422.99
Mar2023 ₹45 Cr
77.84
Dec2022 ₹25 Cr -

NATH BIOGENES (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

-86.83 %

Y-o-Y

-3.37 %

Quarters Operating Profit % Change
Sep2024 ₹5 Cr
-86.83
Jun2024 ₹37 Cr
830.12
Mar2024 ₹4 Cr
-30.43
Dec2023 ₹6 Cr
13.35
Sep2023 ₹5 Cr
-86.47
Jun2023 ₹37 Cr
835.19
Mar2023 ₹4 Cr
-29.90
Dec2022 ₹6 Cr -
Operating Margins
Q-o-Q

-0.20 %

Y-o-Y

-32.26 %

Quarters Operating Margin% % Change
Sep2024 14.95%
-0.20
Jun2024 14.98%
64.07
Mar2024 9.13%
-48.68
Dec2023 17.79%
-19.39
Sep2023 22.07%
41.11
Jun2023 15.64%
78.74
Mar2023 8.75%
-60.59
Dec2022 22.2% -

NATH BIOGENES (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-96.66 %

Y-o-Y

-25.78 %

Quarters Profit After Tax % Change
Sep2024 ₹1 Cr
-96.66
Jun2024 ₹33 Cr
1,897.25
Mar2024 ₹2 Cr
-56.27
Dec2023 ₹4 Cr
154.43
Sep2023 ₹2 Cr
-95.48
Jun2023 ₹33 Cr
2,207.51
Mar2023 ₹1 Cr
6.60
Dec2022 ₹1 Cr -
PAT Margins
Q-o-Q

-74.71 %

Y-o-Y

-47.97 %

Quarters PAT Margin(%) % Change
Sep2024 3.46 %
-74.71
Jun2024 13.68 %
252.58
Mar2024 3.88 %
-67.75
Dec2023 12.03 %
80.90
Sep2023 6.65 %
-52.84
Jun2023 14.1 %
340.63
Mar2023 3.2 %
-39.96
Dec2022 5.33 % -

NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-96.64 %

Y-o-Y

-26.25 %

Quarters EPS % Change
Sep2024 ₹0.59
-96.64
Jun2024 ₹17.55
1,171.74
Mar2024 ₹1.38
-31.34
Dec2023 ₹2.01
151.25
Sep2023 ₹0.8
-95.42
Jun2023 ₹17.47
2,198.68
Mar2023 ₹0.76
7.04
Dec2022 ₹0.71 -

You may also like the below Video Courses